Guangxi LiuYao Group Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Guangxi LiuYao Group ha un patrimonio netto totale di CN¥8.3B e un debito totale di CN¥4.4B, che porta il suo rapporto debito/patrimonio netto a 53.8%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥22.0B e CN¥13.8B. L'EBIT di Guangxi LiuYao Group è CN¥1.3B rendendo il suo rapporto di copertura degli interessi 7.4. Ha liquidità e investimenti a breve termine pari a CN¥3.3B.

Informazioni chiave

53.8%

Rapporto debito/patrimonio netto

CN¥4.45b

Debito

Indice di copertura degli interessi	7.4x
Contanti	CN¥3.30b
Patrimonio netto	CN¥8.27b
Totale passività	CN¥13.77b
Totale attività	CN¥22.03b

Aggiornamenti recenti sulla salute finanziaria

Guangxi LiuYao Group (SHSE:603368) Has A Pretty Healthy Balance Sheet

May 21

Recent updates

Guangxi LiuYao Group's (SHSE:603368) Promising Earnings May Rest On Soft Foundations

Nov 05

Returns On Capital Signal Tricky Times Ahead For Guangxi LiuYao Group (SHSE:603368)

Oct 28

Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Intrinsic Value Is Potentially 22% Below Its Share Price

Aug 07

Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Mar 04

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CN¥19.5B ) di 603368 superano le sue passività a breve termine ( CN¥12.2B ).

Passività a lungo termine: Le attività a breve termine di 603368 ( CN¥19.5B ) superano le sue passività a lungo termine ( CN¥1.6B ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 13.9% ) di 603368 è considerato soddisfacente.

Riduzione del debito: Il rapporto debito/patrimonio netto di 603368 si è ridotto da 64.3% a 53.8% negli ultimi 5 anni.

Copertura del debito: Il debito di 603368 non è ben coperto dal flusso di cassa operativo ( 15.7% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di 603368 sono ben coperti dall'EBIT ( 7.4 x copertura).

Guangxi LiuYao Group Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Guangxi LiuYao Group (SHSE:603368) Has A Pretty Healthy Balance Sheet

Recent updates

Guangxi LiuYao Group's (SHSE:603368) Promising Earnings May Rest On Soft Foundations

Third quarter 2024 earnings released: EPS: CN¥0.63 (vs CN¥0.64 in 3Q 2023)

Returns On Capital Signal Tricky Times Ahead For Guangxi LiuYao Group (SHSE:603368)

Guangxi LiuYao Group Co., Ltd to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings released: EPS: CN¥0.42 (vs CN¥0.50 in 2Q 2023)

Now 21% overvalued

Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Intrinsic Value Is Potentially 22% Below Its Share Price

Guangxi LiuYao Group Co., Ltd to Report First Half, 2024 Results on Aug 29, 2024

Guangxi LiuYao Group (SHSE:603368) Is Increasing Its Dividend To CN¥0.60

Dividend increased to CN¥0.60

Guangxi LiuYao Group (SHSE:603368) Has A Pretty Healthy Balance Sheet

Guangxi LiuYao Group's (SHSE:603368) Earnings Are Weaker Than They Seem

New major risk - Financial position

First quarter 2024 earnings released: EPS: CN¥0.83 (vs CN¥0.72 in 1Q 2023)

Guangxi LiuYao Group Co., Ltd, Annual General Meeting, May 17, 2024

A Look At The Fair Value Of Guangxi LiuYao Group Co., Ltd (SHSE:603368)

Guangxi LiuYao Group Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024

Full year 2023 earnings released: EPS: CN¥2.34 (vs CN¥1.94 in FY 2022)

Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Investor sentiment improves as stock rises 15%

Guangxi LiuYao Group Co., Ltd to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.64 (vs CN¥0.57 in 3Q 2022)

Guangxi LiuYao Group Co., Ltd to Report Q3, 2023 Results on Oct 26, 2023

Price target decreased by 24% to CN¥25.19

Second quarter 2023 earnings released: EPS: CN¥0.50 (vs CN¥0.41 in 2Q 2022)

Now 22% undervalued after recent price drop

Investor sentiment improves as stock rises 22%

Guangxi LiuYao Group Co., Ltd to Report First Half, 2023 Results on Aug 29, 2023

Now 21% undervalued after recent price drop

First quarter 2023 earnings released: EPS: CN¥0.72 (vs CN¥0.61 in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥1.91 (vs CN¥1.56 in FY 2021)

Guangxi LiuYao Group Co., Ltd (SHSE:603368) announces an Equity Buyback for CNY 100 million worth of its shares.

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.47 in 3Q 2021)

First quarter 2022 earnings: EPS misses analyst expectations

Price target decreased to CN¥23.53

Less than half of directors are independent

Full year 2021 earnings: EPS misses analyst expectations

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.47 (vs CN¥0.59 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.34 (vs CN¥0.58 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥1.96 (vs CN¥1.90 in FY 2019)

Guangxi Liuzhou Pharmaceutical Co., Ltd. to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day low: CN¥20.16

New 90-day low: CN¥21.59

Analysts lower EPS estimates to CN¥2.31

Third quarter earnings released

New 90-day low: CN¥22.97

New 90-day low: CN¥23.29

First half earnings released

New 90-day high - CN¥27.40

Guangxi Liuzhou Pharmaceutical Co., Ltd. to Report First Half, 2020 Results on Aug 20, 2020

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane